Insufficient scRNA-seq data for expression of KCND1 at single-cell level.
Insufficient scRNA-seq data for expression of KCND1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 98% | 668.72 | 2593 / 2642 | 100% | 9.66 | 702 / 705 |
ovary | 100% | 564.37 | 180 / 180 | 89% | 4.30 | 381 / 430 |
lung | 100% | 535.48 | 577 / 578 | 85% | 2.68 | 986 / 1155 |
thymus | 100% | 413.63 | 652 / 653 | 84% | 1.99 | 511 / 605 |
uterus | 100% | 764.54 | 170 / 170 | 83% | 3.35 | 379 / 459 |
skin | 97% | 238.82 | 1762 / 1809 | 84% | 3.38 | 395 / 472 |
breast | 100% | 396.51 | 459 / 459 | 79% | 1.96 | 884 / 1118 |
esophagus | 97% | 282.72 | 1406 / 1445 | 77% | 2.18 | 141 / 183 |
bladder | 100% | 464.10 | 21 / 21 | 71% | 2.01 | 356 / 504 |
pancreas | 73% | 120.44 | 238 / 328 | 95% | 4.09 | 169 / 178 |
prostate | 100% | 510.20 | 245 / 245 | 67% | 1.24 | 337 / 502 |
adrenal gland | 86% | 165.10 | 222 / 258 | 80% | 5.03 | 183 / 230 |
kidney | 100% | 331.10 | 89 / 89 | 62% | 1.61 | 563 / 901 |
stomach | 95% | 314.17 | 342 / 359 | 63% | 1.67 | 179 / 286 |
intestine | 100% | 416.70 | 965 / 966 | 57% | 1.28 | 302 / 527 |
spleen | 100% | 680.96 | 241 / 241 | 0% | 0 | 0 / 0 |
adipose | 100% | 592.15 | 1201 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 99% | 480.40 | 1322 / 1335 | 0% | 0 | 0 / 0 |
liver | 79% | 143.22 | 178 / 226 | 20% | 0.53 | 81 / 406 |
peripheral blood | 98% | 490.56 | 914 / 929 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 90% | 4.19 | 26 / 29 |
tonsil | 0% | 0 | 0 / 0 | 82% | 2.15 | 37 / 45 |
heart | 82% | 234.98 | 706 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 39% | 0.72 | 31 / 80 |
muscle | 23% | 29.76 | 185 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0051260 | Biological process | protein homooligomerization |
GO_0001508 | Biological process | action potential |
GO_0071805 | Biological process | potassium ion transmembrane transport |
GO_0005575 | Cellular component | cellular_component |
GO_0043025 | Cellular component | neuronal cell body |
GO_0043197 | Cellular component | dendritic spine |
GO_0005886 | Cellular component | plasma membrane |
GO_0008076 | Cellular component | voltage-gated potassium channel complex |
GO_0045211 | Cellular component | postsynaptic membrane |
GO_0005250 | Molecular function | A-type (transient outward) potassium channel activity |
GO_0046872 | Molecular function | metal ion binding |
Gene name | KCND1 |
Protein name | Potassium voltage-gated channel subfamily D member 1 Potassium voltage-gated channel subfamily D member 1 (Voltage-gated potassium channel subunit Kv4.1) |
Synonyms | |
Description | FUNCTION: Pore-forming (alpha) subunit of voltage-gated rapidly inactivating A-type potassium channels. May contribute to I(To) current in heart and I(Sa) current in neurons. Channel properties are modulated by interactions with other alpha subunits and with regulatory subunits. |
Accessions | H7C3V4 Q9NSA2 ENST00000419374.1 ENST00000710082.1 [Q9NSA2-1] ENST00000710081.1 [Q9NSA2-2] ENST00000218176.4 [Q9NSA2-1] ENST00000376477.5 [Q9NSA2-2] |